Literature DB >> 10810110

Epidemiological survey of workers exposed to inorganic germanium compounds.

B Swennen1, A Mallants, H A Roels, J P Buchet, A Bernard, R R Lauwerys, D Lison.   

Abstract

OBJECTIVES: To assess occupational exposure to inorganic germanium (Ge) in workers from a producing plant, and to assess the health of these workers, with a special focus on respiratory, kidney, and liver functions.
METHODS: Cross sectional study of 75 workers exposed to Ge and 79 matched referents. Exposure was characterised by measuring air and urine concentrations of the element during a typical working week, and health was assessed by a questionnaire, clinical examination, lung function testing, chest radiography, and clinical chemistry in serum and urine, including high and low molecular weight urinary proteins.
RESULTS: Airborne concentrations of Ge (inhalable fraction) ranged from 0.03 to 300 micrograms/m, which was reflected by increased urinary excretion of Ge (0.12-200 micrograms/g creatinine, after the shift at the end of the working week). Lung, liver, and haematological variables were not significantly different between referents and workers exposed to Ge. A slightly higher urinary concentration of high molecular weight proteins (albumin and transferrin) was found in workers exposed to Ge, possibly reflecting subclinical glomerular changes. No relation was found between the intensity or duration of exposure and the urinary concentration of albumin. No difference between referents and workers exposed to Ge was found for other renal variables.
CONCLUSIONS: Measurement of urinary Ge can detect occupational exposure to inorganic Ge and its compounds. It is prudent to recommend the monitoring of renal variables in workers exposed to Ge.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810110      PMCID: PMC1739927          DOI: 10.1136/oem.57.4.242

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  17 in total

1.  Dangers of dietary germanium supplements.

Authors:  J I van der Spoel; B H Stricker; M R Esseveld; M E Schipper
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

2.  Germanium myopathy: clinical and experimental pathological studies.

Authors:  I Higuchi; S Izumo; M Kuriyama; M Suehara; M Nakagawa; H Fukunaga; M Osame; S Ohtsubo; K Miyata
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Renal failure caused by long-term use of a germanium preparation as an elixir.

Authors:  K Okada; K Okagawa; K Kawakami; Y Kuroda; K Morizumi; H Sato; H Morita; S Shimomura; S Saito
Journal:  Clin Nephrol       Date:  1989-04       Impact factor: 0.975

4.  Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids.

Authors:  H S Margolius; D Horwitz; R G Geller; R W Alexander; J R Gill; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

Review 5.  Hazard assessment of germanium supplements.

Authors:  S H Tao; P M Bolger
Journal:  Regul Toxicol Pharmacol       Date:  1997-06       Impact factor: 3.271

6.  Subacute nephrotoxicity of germanium dioxide in the experimental animal.

Authors:  T Sanai; N Oochi; S Okuda; S Osato; S Kiyama; T Komota; K Onoyama; M Fujishima
Journal:  Toxicol Appl Pharmacol       Date:  1990-04       Impact factor: 4.219

Review 7.  Cadmium: exposure markers as predictors of nephrotoxic effects.

Authors:  R R Lauwerys; A M Bernard; H A Roels; J P Buchet
Journal:  Clin Chem       Date:  1994-07       Impact factor: 8.327

8.  Effects of germanium and silicon on bone mineralization.

Authors:  C D Seaborn; F H Nielsen
Journal:  Biol Trace Elem Res       Date:  1994-08       Impact factor: 3.738

9.  Acute and subacute inhalation toxicity of germanium dioxide in rats.

Authors:  J H Arts; H P Til; C F Kuper; R de Neve; B Swennen
Journal:  Food Chem Toxicol       Date:  1994-11       Impact factor: 6.023

Review 10.  Germanium-induced nephropathy: report of two cases and review of the literature.

Authors:  T Matsusaka; M Fujii; T Nakano; T Terai; A Kurata; M Imaizumi; H Abe
Journal:  Clin Nephrol       Date:  1988-12       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.